Dr. Robert S. Gillespie, MD

Dr. Gillespie practices at Cook Children's Medical Center in Fort Worth, Texas, part of Cook Children's Health Care System.

Dr. Gillespie's NPI, 1912043738, was assigned on January 29, 2007. Dr. Gillespie graduated from UTMB Health in 1997. Dr. Gillespie holds Texas license L6910.

Dr. Gillespie's primary practice is Cook Children's Medical Center, at 801 Seventh Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (682) 885-4000.

Dr. Gillespie's primary practice is Cook Children's Medical Center in Fort Worth, Texas, part of Cook Children's Health Care System. The medical group on file is Cook Childrens Physician Network. Dmand AI also links Dr. Gillespie to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gillespie practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Gillespie's primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Gillespie is board certified in pediatric nephrology by the American Board of Pediatrics. Dmand AI has Dr. Gillespie's licenses on file in 3 states: Texas, South Carolina and Washington.

CMS data shows 44 Medicare services from Dr. Gillespie across 1 procedure code in 2024, for 22 Medicare patients. Medicare paid $4,041 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Gillespie in 2024. The largest group is under 65, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 5.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gillespie's median patient age at 14, with 40% women.

In 2024, Dr. Gillespie wrote 164 Medicare Part D claims. 80% of them were for generic drugs. CMS names the drug for 117 of them, across 8 drugs with 11 or more claims each, at $813,799 in total drug cost. In 2023, CMS named 145 claims across 8 drugs.

Dr. Gillespie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Gillespie, published from 2002 to 2020. The most frequent topics are Erythropoietin, Hemoglobins and Immunosuppressive Agents. Dr. Gillespie has published most often in Pediatr Nephrol. Dr. Gillespie's most frequent co-authors are Badreldin M. Bedri, MD, Wesley Mark Hiser and Jason Wang, MD.

CMS Open Payments shows 91 general payments to Dr. Gillespie from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 26% of the total. Sanofi and Genzyme US Companies paid the most, $4,160.

Dr. Gillespie graduated from UTMB Health in 1997.

Dr. Gillespie is in network with 9 carriers, including Aetna, United Healthcare and Elevance. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.